actrapid penfill & flexpen, 100 iu/ml (5 x 3ml) solution for injection
novo nordisk a/s novo alle dk-2880 bagsvaerd denmark - insulin human - solution for injection - 100 iu/ml - insulins and analogues for injection fast-acting
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.
insulin lispro sanofi
sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.
actrapid
novo nordisk a/s - insulin human (recombinant dna) - solution for injection - 100iu/ml
actrapid solution for injection
novo nordisk production sas - insulin human (recombinant dna) - solution for injection - 100iu/ml
actrapid penfill solution for injection
novo nordisk a/s - insulin human - solution for injection - 100iu/ml
actrapid solution for injection
novo nordisk a/s - insulin human (recombinant dna) - solution for injection - 100iu/ml
actrapid flexpen injection 100
novo nordisk a/s, denmark - human insulin - injection - 100
actrapid flexpen
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml; - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.
actrapid innolet
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml; - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.